Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)

China · Delayed Price · Currency is CNY

3.850

+0.160 (4.34%)

Aug 4, 2026, 3:04 PM CST

SHE:000518 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	381.71	344.38	203.52	235.42	270.15	350.96
Revenue Growth	99.89%	69.22%	-13.55%	-12.86%	-23.03%	-30.56%
Gross Profit	109.53	122.23	90.11	147.34	183.79	235.85
Operating Income	-42.16	-44.2	-68.29	-67.21	-49.56	-35.16
Net Income	-32.49	-37.09	-109.99	-75.27	-48.79	-34.79
Earnings Per Share	-0.03	-0.04	-0.11	-0.07	-0.05	-0.03
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Medicine	184.76	198.1
Others	1.01	1.33
Forest	158.62	4.09
Total	344.38	203.52

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	75.12	89.69	8.18	19.06	28.34	38.34
Total Debt	40.9	30.16	36.27	47.9	48.75	51.1
Net Cash (Debt)	34.22	59.54	-28.09	-28.84	-20.41	-12.77
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.03	0.06	-0.03	-0.03	-0.02	-0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	52.57	78.12	1.46	1.63	4.87	0.16
Capital Expenditures	-3.65	-3.6	-5.56	-8.19	-8.47	-7.69
Free Cash Flow	48.92	74.52	-4.1	-6.56	-3.61	-7.53
Free Cash Flow Growth	3547.49%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	28.69%	35.49%	44.27%	62.59%	68.03%	67.20%
Operating Margin	-11.05%	-12.83%	-33.56%	-28.55%	-18.34%	-10.02%
Pretax Margin	-9.50%	-11.88%	-55.88%	-33.74%	-19.84%	-10.27%
Profit Margin	-8.51%	-10.77%	-54.05%	-31.97%	-18.06%	-9.91%
FCF Margin	12.82%	21.64%	-2.01%	-2.79%	-1.34%	-2.15%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
P/FCF Ratio	81.02	33.30	-	-	-	-
PS Ratio	10.38	7.21	12.80	14.52	12.08	10.65